Suppr超能文献

纳米抗体导向的多功能 T 细胞衔接子通过协同免疫-光热效应促进强烈的抗肿瘤反应。

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.

机构信息

Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China.

Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China.

出版信息

J Nanobiotechnology. 2024 Sep 14;22(1):561. doi: 10.1186/s12951-024-02781-1.

Abstract

BACKGROUND

T cell-based immunotherapies are facing great challenges in the recruitment and activation of tumor-specific T cells against solid tumors. Among which, utilizing nanobody (Nb) or nanobodies (Nbs) to construct T cell engager has emerged as a more practical potential for enhancing the anti-tumor effectiveness of T cells. Here, we designed a new Nb-guided multifunctional T cell engager (Nb-MuTE) that not only recruited effector T cells into the tumor tissues, but also efficiently activated T cells anti-tumor immunity when synergies with photothermal effect.

RESULTS

The Nb-MuTE, which was constructed based on an indocyanine green (ICG)-containing liposome with surface conjugation of CD105 and CD3 Nbs, and showed excellent targetability to both tumor and T cells, following enhancement of activation, proliferation and cytokine secretion of tumor-specific T cells. Notably, the immunological anti-tumor functions of Nb-MuTE-mediated T cells were further enhanced by the ICG-induced photothermal effect in vitro and in vivo.

CONCLUSIONS

Such a new platform Nb-MuTE provides a practical and "all-in-one" strategy to potentiate T cell responses for the treatment of solid tumor in clinic.

摘要

背景

T 细胞为基础的免疫疗法在募集和激活针对实体瘤的肿瘤特异性 T 细胞方面面临巨大挑战。其中,利用纳米抗体(Nb)或纳米抗体(Nbs)构建 T 细胞衔接器已成为增强 T 细胞抗肿瘤效果的一种更实用的潜力。在这里,我们设计了一种新的纳米抗体引导的多功能 T 细胞衔接器(Nb-MuTE),它不仅可以募集效应 T 细胞进入肿瘤组织,而且在与光热效应协同作用时还可以有效地激活 T 细胞抗肿瘤免疫。

结果

Nb-MuTE 是基于含有吲哚菁绿(ICG)的脂质体构建的,表面连接有 CD105 和 CD3 Nbs,对肿瘤和 T 细胞均具有优异的靶向性,可增强肿瘤特异性 T 细胞的激活、增殖和细胞因子分泌。值得注意的是,ICG 诱导的光热效应对 Nb-MuTE 介导的 T 细胞的免疫抗肿瘤功能具有进一步的增强作用,无论是在体外还是体内。

结论

这种新的平台 Nb-MuTE 为临床治疗实体瘤提供了一种实用的“一体化”策略,以增强 T 细胞的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c9a/11401270/a5e5e942525d/12951_2024_2781_Fig1_HTML.jpg

相似文献

2
Enhancing Tumor Immunotherapy by Multivalent Anti-PD-L1 Nanobody Assembled via Ferritin Nanocage.
Adv Sci (Weinh). 2024 May;11(20):e2308248. doi: 10.1002/advs.202308248. Epub 2024 Mar 16.
4
Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function.
Mol Immunol. 2020 Feb;118:174-181. doi: 10.1016/j.molimm.2019.12.017. Epub 2019 Dec 26.
5
Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria.
Theranostics. 2024 Sep 9;14(15):5945-5964. doi: 10.7150/thno.98257. eCollection 2024.
6
ICG-labeled PD-L1-antagonistic affibody dimer for tumor imaging and enhancement of tumor photothermal-immunotherapy.
Int J Biol Macromol. 2024 Jun;269(Pt 2):132058. doi: 10.1016/j.ijbiomac.2024.132058. Epub 2024 May 3.
9
Development of Indocyanine Green/Methyl-β-cyclodextrin Complex-Loaded Liposomes for Enhanced Photothermal Cancer Therapy.
ACS Appl Mater Interfaces. 2024 Jul 3;16(26):32945-32956. doi: 10.1021/acsami.4c01078. Epub 2024 Jun 24.

引用本文的文献

1
Nanobodies and their derivatives: pioneering the future of cancer immunotherapy.
Cell Commun Signal. 2025 Jun 5;23(1):271. doi: 10.1186/s12964-025-02270-4.
2
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.
Lipids Health Dis. 2025 Jan 31;24(1):31. doi: 10.1186/s12944-024-02429-x.

本文引用的文献

1
Chimeric nanobody-decorated liposomes by self-assembly.
Nat Nanotechnol. 2024 Jun;19(6):818-824. doi: 10.1038/s41565-024-01620-6. Epub 2024 Feb 19.
3
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20.
4
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy.
Signal Transduct Target Ther. 2023 Sep 4;8(1):328. doi: 10.1038/s41392-023-01523-3.
5
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2216612120. doi: 10.1073/pnas.2216612120. Epub 2023 Jun 5.
6
T-cell-engaging bispecific antibodies in cancer.
Lancet. 2023 Jul 8;402(10396):142-158. doi: 10.1016/S0140-6736(23)00521-4. Epub 2023 Jun 1.
7
Nanobodies in cell-mediated immunotherapy: On the road to fight cancer.
Front Immunol. 2023 Jan 25;14:1012841. doi: 10.3389/fimmu.2023.1012841. eCollection 2023.
8
Nanobodies made versatile.
Nat Methods. 2023 Jan;20(1):37. doi: 10.1038/s41592-022-01757-z.
9
Indocyanine Green Fluorescence Navigation in Liver Surgery: A Systematic Review on Dose and Timing of Administration.
Ann Surg. 2022 Jun 1;275(6):1025-1034. doi: 10.1097/SLA.0000000000005406. Epub 2022 Feb 2.
10
Photogenerated-hole-induced rapid elimination of solid tumors by the supramolecular porphyrin photocatalyst.
Natl Sci Rev. 2020 Jul 2;8(5):nwaa155. doi: 10.1093/nsr/nwaa155. eCollection 2021 May.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验